Search Tag: SARS-CoV-2

ICU Management

Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

2021 19 Jan

Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately  $450 million  in cash. Under the terms of the agreement,  Thermo Fisher  will pay up to an additional  $100 million... Read more

Decision Support

`Molecular Tests are Pivotal in Combating the COVID-19 Pandemic`

2020 28 Oct

The central laboratory of the Niels-Stensen-Kliniken group in Osnabrück wasted no time in setting up its own test facilities for the molecular detection of SARS-CoV-2. We spoke with Michael Erren, MD, Head of the Institute for Laboratory Medicine about his strategy and the importance of diagnostic molecular testing in fighting the pandemic.... Read more

Executive Health Management

J&J’s Vaccine Trial Paused

2020 13 Oct

Johnson & Johnson has announced temporarily pausing the COVID-19 vaccine candidate trials due to an unexplained illness in a study participant.   You might also like: Rushing COVID-19 Vaccine Development: Is It Justified?   As reported by STAT News, the company has informed external researchers through a document that a “passing... Read more

IMAGING Management

FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay

2020 06 Oct

Hologic, Inc.  announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in May, is now authorized for testing of individuals without symptoms or other reasons to suspect COVID-19 infection. This authorization follows an  announcement  last week... Read more

Health Management

Volume 20 - Issue 7, 2020

2020 28 Sep

Change content default value Read more

Executive Health Management

How Exposure to SARS-CoV-2 Varies Across Hospital Settings

2020 24 Sep

New research from the UK has detected SARS-CoV-2 seroconversion among asymptomatic healthcare workers. Moreover, researchers were able to identify variation in the occupational risk of exposure to the pathogen – which causes COVID-19 – between hospital departments.   You might also like: COVID-19: Risk Factors for Healthcare Workers... Read more

Executive Health Management

Siemens Healthineers Collaboration With CDC To Standardize SARS-CoV-2 Assays

2020 15 Sep

The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level... Read more

Executive Health Management

Siemens Healthineers Collaboration With CDC To Standardize SARS-CoV-2 Assays

2020 15 Sep

The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity. Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level... Read more

IMAGING Management

Hologic Launches Validated Pooling Protocol for COVID-19 Testing

2020 11 Aug

In Time of Extraordinary Need, New Protocol Expected to Help Laboratories Deliver Greater Quantities of Highly Accurate Molecular Test Results and Reduce Turnaround Times  Hologic, Inc.  announced today that it has validated use of its Aptima® and Panther Fusion® molecular diagnostic COVID-19 assays with pooled patient samples and completed... Read more

Executive Health Management

New Sample Pooling Method for COVID-19 Testing

2020 06 Aug

Widespread testing for COVID-19 derives important epidemiological data that can inform strategies on disease monitoring and control. However, shortages of test kits and bottlenecks in processing of results prevent many countries from implementing mass testing. This leaves many patients (especially those not showing symptoms) untested, increasing... Read more